Cargando…

SARS‐CoV‐2 Clinical Outcomes in Patients with Cancer in a Large Integrated Health Care System in Northern California

The SARS‐CoV‐2 (COVID‐19) pandemic continues to affect many lives globally. Patients with cancer undergoing potentially immunosuppressive therapies appear to be at particular risk for the disease and its complications. Here, we describe the experience of patients with cancer within Kaiser Permanente...

Descripción completa

Detalles Bibliográficos
Autores principales:	Anantharaman, Archana, Dusendang, Jennifer R., Schmittdiel, Julie A., Harzstark, Andrea L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2020
Materias:	Brief Communications
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7753632/ https://www.ncbi.nlm.nih.gov/pubmed/33210439 http://dx.doi.org/10.1002/onco.13602

Ejemplares similares

Prior Immunosuppressive Therapy and Severe Illness Among Patients Diagnosed with SARS-CoV-2: a Community-Based Study
por: Velayos, Fernando S., et al.
Publicado: (2021)

Association of anticoagulation use with SARS-CoV2 detection()
por: Kavecansky, Juraj, et al.
Publicado: (2021)

SARS-CoV-2 Testing, Prevalence, and Predictors of COVID-19 in Patients with Inflammatory Bowel Disease in Northern California
por: Gubatan, John, et al.
Publicado: (2020)

Association of chronic anticoagulant and antiplatelet use on disease severity in SARS-COV-2 infected patients
por: Ho, Gwendolyn, et al.
Publicado: (2021)

Identifying Predictors of Homelessness Among Adults in a Large Integrated Health System in Northern California
por: Rodriguez, Luis A, et al.
Publicado: (2023)

Anti-SARS-CoV-2 spike protein and neutralizing antibodies at 1 and 3 months after three doses of SARS-CoV-2 vaccine in a large cohort of solid organ transplant patients
por: Kamar, Nassim, et al.
Publicado: (2022)

252 PREDNISONE, BUT NOT BIOLOGICS OR IMMUNOMODULATORS ARE ASSOCIATED WITH SEVERE COVID-19 OUTCOMES: A COMMUNITY BASED STUDY
por: Velayos, Fernando, et al.
Publicado: (2021)

Substantial differences in soil viral community composition within and among four Northern California habitats
por: Durham, Devyn M., et al.
Publicado: (2022)

SARS-CoV-2 vaccines in patients with SLE
por: Tang, Wei, et al.
Publicado: (2021)

Genomic surveillance reveals multiple introductions of SARS-CoV-2 into Northern California
por: Deng, Xianding, et al.
Publicado: (2020)

SARS-CoV-2 and Perceived Physical, Mental and Social Health in Northern California
por: Fast, Katharine, et al.
Publicado: (2022)

Secondary structure of the SARS-CoV-2 5’-UTR
por: Miao, Zhichao, et al.
Publicado: (2020)

Direct on-the-spot detection of SARS-CoV-2 in patients
por: Ben-Assa, Nadav, et al.
Publicado: (2020)

Bayesian estimation of the seroprevalence of antibodies to SARS-CoV-2
por: Dong, Qunfeng, et al.
Publicado: (2020)

Neutralisation of SARS‐CoV‐2 by anatomical embalming solutions
por: Quondamatteo, Fabio, et al.
Publicado: (2021)

Effects of Smoking on SARS-CoV-2 Positivity: A Study of a Large Health System in Northern and Central California
por: Li, Jiang, et al.
Publicado: (2022)

Prevalence of a Single-Nucleotide Variant of SARS-CoV-2 in Korea and Its Impact on the Diagnostic Sensitivity of the Xpert Xpress SARS-CoV-2 Assay
por: Hong, Ki Ho, et al.
Publicado: (2022)

Co‐infection of malaria and dengue in pregnant women with SARS‐CoV‐2
por: Mahajan, Niraj N., et al.
Publicado: (2020)

SARS-CoV-2: too infectious to handle?
por: Coveney, Clarissa, et al.
Publicado: (2020)

To Transplant or Not to Transplant During the SARS‐CoV‐2 Pandemic? That Is the Question
por: Marino, Dario, et al.
Publicado: (2020)

Haemophilus influenzae and SARS-CoV-2: Is there a role for investigation?
por: Borkakoty, Biswajyoti, et al.
Publicado: (2021)

Mutation signatures inform the natural host of SARS-CoV-2
por: Deng, Shanjun, et al.
Publicado: (2021)

Emergence of SARS-CoV-2 serotype(s): Is it a matter of time?
por: Silva Júnior, José Valter Joaquim, et al.
Publicado: (2023)

Symptom Profiles and Risk Factors for Hospitalization in Patients With SARS-CoV-2 and COVID-19: A Large Cohort From South America
por: Díaz, Luis Antonio, et al.
Publicado: (2020)

Effortful speech with distortion of prosody following SARS-CoV-2 infection
por: Cotelli, Maria Sofia, et al.
Publicado: (2020)

Virus Isolation from the First Patient with SARS-CoV-2 in Korea
por: Park, Wan Beom, et al.
Publicado: (2020)

Sociodemographic characteristics and healthcare utilization of infants with SARS-CoV-2 in the U.S
por: Yieh, Leah, et al.
Publicado: (2023)

Association of Lower Socioeconomic Status and SARS-CoV-2 Positivity in Los Angeles, California
por: Allan-Blitz, Lao-Tzu, et al.
Publicado: (2021)

No indication for SARS-CoV-2 transmission to pet ferrets, in five cities in Poland, 2021 - antibody testing among ferrets living with owners infected with SARS-CoV-2 or free of infection
por: Kaczorek-Łukowska, Edyta, et al.
Publicado: (2023)

Immunogenicity of SARS-CoV-2 spike antigens derived from Beta & Delta variants of concern
por: Akache, Bassel, et al.
Publicado: (2022)

Are mobile phones part of the chain of transmission of SARS-CoV-2 in hospital settings?
por: Espinoza, Evelyn Patricia Sánchez, et al.
Publicado: (2021)

Transient acquisition of cross-species infectivity during the evolution of SARS-CoV-2
por: Chen, Qi, et al.
Publicado: (2021)

Effectiveness of Disinfectants Suitable for Inactivating SARS-CoV-2 at Cold-Chain Temperature
por: Wu, Xiaosong, et al.
Publicado: (2022)

Time of Bariatric Surgery and Hospitalization for SARS-CoV-2: a Nationwide Study
por: Poghosyan, Tigran, et al.
Publicado: (2021)

Antibody Responses One Year after Mild SARS-CoV-2 Infection
por: Choe, Pyoeng Gyun, et al.
Publicado: (2021)

Ancestral SARS-CoV-2-specific T cells cross-recognize the Omicron variant
por: Gao, Yu, et al.
Publicado: (2022)

Immunogenicity of candidate SARS-CoV-2 DNA vaccines based on the spike protein
por: Lim, Heeji, et al.
Publicado: (2022)

Vaccines against SARS‐CoV‐2 are safe to administer in patients with antibodies to pegaspargase
por: Swanson, Hope D., et al.
Publicado: (2022)

Attacking the defence: SARS-CoV-2 can infect immune cells
por: Borsa, Mariana, et al.
Publicado: (2020)

CD8(+) T cells remember same bits of SARS-CoV-2
por: Mazet, Julie M., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_4mpbq7polakhhhm5pcp333d01n